Abstract
Thyrotropin-releasing hormone (TRH) is a hypothalamic hormone that releases thyrotropin and prolactin from the anterior pituitary, and is widely distributed throughout the central nervous system (CNS).1–5 It has been shown to have various central actions, such as promoting locomotor activity, increasing body temperature in animals, attenuating pentobarbital induced sleep, and promoting recovery from traumatic loss of consciousness in mice.6–10 TRH also increases cholinergic neuronal activity11–14 and improves memory in amnesia models.15 Currently TRH and its analogues are under clinical investigation for treating spinal cord injury, traumatic brain injury, and dementia including Alzheimer’s disease.16–18 However, TRH has some disadvantages for therapeutic use, including a short duration of action and unsuitability for oral administration. Accordingly, we synthesized a novel TRH analogue, Nα-WS, 2R)-2-methyl-4-oxocyclopentanecarbonyl]-L-histidyl-L-prolineamide monohydrate (JTP2942), with a longer duration of action on the CNS and fewer hormonal effects than TRH.19–21 JTP-2942 has been shown to markedly increase CNS cholinergic neuronal activity22 and improve memory in amnesia models and aged animals.23,24 The callosal-neocortical system is implicated in interhemispheric transfer of the engram and the lateralization of information.25–27 The present study investigated whether JTP-2942 could improve cognitive function and learning in rats subjected to a passive avoidance test after transection of the corpus callosum, and investigated the mechanism of action of this drug using the transcallosal response.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J. Boler, F.M. Enzmann, K. Folkers, C. Bowers, and A.V. Schalley, The identity of chemical and hormonal properties of thyrotropin-releasing hormone and pyroglutamyl-histidyl-prolineamide, Biochem. Biophys. Res. Commun. 37: 705 (1969).
M.J. Brownstein, M. Palkovits, J.M. Saavedra, R.M. Bassin, and R.D. Utiger, Thyrotropin-releasing hormone in specific nuclei of rat brain, Science 185: 267 (1974).
J.E. Morley, Extrahypothalamic thyrotropin releasing hormone (TRH) - its distribution and its functions, Life Sci. 25: 1539 (1979).
P.C. Emson, G.W. Bennet, and M.N. Rossor, The distribution and characterization of thyrotropin releasing hormone (TRH) in the human brain, Neuropeptides 2: 115 (1981).
C.R. Parker Jr., and J.C. Porter, Regional localization and subcellular compartmentalization of thyrotropin releasing hormone in adult human brain, J. Neurochem. 41: 1614 (1983).
G.G. Yarbrough, On the neuropharmacology of thyrotropin releasing hormone (TRH), Progr. Neurobiol. 12: 291 (1979).
M. Yamamoto, and M. Shimizu, Effect of a new TRH analogue, YM-14673 on the central nervous system, Naunyn-Schmiedeberg’s Arch. Pharmacol. 336: 561 (1987).
G.R. Breese, J.M. Cott, B.R.Cooper, A. J. Prange, M.A. Jr. Lipton, and N.P. Plotnikoff, Effect of thyrotropin releasing hormone (TRH) on the action of pentobarbital and other centrally acting drugs, J. Pharmacol. Exp. Ther. 193: 11 (1975).
D.E. Schmidt, Effect of thyrotropin releasing hormone (TRH) on pentobarbital-induced decrease in cholinergie neuronal activity, Comm. Pychopharmacol. 1: 469 (1977).
M. Yamamura, K. Kinoshita, H. Nakagawa, and R. Ishida, Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analogue (II); Inhibition of pentobarbital anesthesia, Jpn. J. Pharmacol. 55: 69 (1991).
S. Narumi, Y. Nagai, M. Miyamoto, and Y. Nagawa, Thyrotropin-releasing hormone (TRH) and its analogue (DN-1417): interaction with pentobarbital in choline uptake and acetylcholine synthesis of rat brain slice, Life Sci. 32: 1637 (1983).
M.G. Giovannini, F Casamenti, A. Nistri, F. Paoli, and G. Pepeu, Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis, Br. J. Pharmacol. 102: 363 (1991).
M. Okada, Effect of a new thyrotropin releasing hormone analogue, YM-14673, on the in vivo release of acetylcholine as measured by intracerebral dialysis in rats, J. Neurochem. 56: 1544 (1991).
N. Brunello, and D.L. Cheney, The septal-hippocampal cholinergie pathway: role in antagonism of pentobarbital anesthesia and regulation by various afferents, J. Pharmacol. Exp. Mer. 219: 489 (1981).
M. Yamamoto, and M. Shimizu, Effect of a new TRH analogue, YM-14673 on a passive avoidance test as a possible criterion of improvement in cognitive disturbance in rodents, Naunyn-Schmiedeberg’s Arch. Pharmacol. 338: 262 (1988).
E.C. Griffith, Thyrotropin-releasing hormone. New applications in the clinic, Nature 322: 212 (1986).
E.C. Griffith, Clinical applications of thyrotropin-releasing hormone, Clin. Sci. 73: 449 (1987).
A.I. Farden, and S. Saizman, Pharmacological strategies in CNS trauma, Trends Pharmacol. Sci. 13: 29 (1992).
J. Haruta, K. Sakuma, A. Yasuda, K. Hara, A. Saito, F. Yonemori, M. Matsushita, A. Uemura, K. Iwata, and I. Uchida, The synthesis and pharmacological activities of TRH analogues, Med. Chem Soc. (Abst) 12th Symposium: 52 (1991).
M. Matsushita, F. Yonemori, N. Furukawa, A. Ohta, I. Uchida, and K. Iwata, Effect of the novel thyrotropin-releasing hormone analogue Na-((ls,2R)-2-Methyl-4-oxocyclopentylcarbonyl)-L-histidylL-prolinamide Monohydrate on the central nervous system in mice and rats, Arzneimittel Forsch. Drug Res. 43: 813 (1993).
M. Matsushita, F. Yonemori, A. Hamada, M. Nakae, T. Suzuki, A. Ohta, K. Toide, and K. Iwata, Effect and mechanism of action of a novel TRH analogue, JTP-2942, on recovery from pentobarbital-induced anesthesia in rats, Jpn. J. Pharmacol. 61(Sup.: 113 (1993).
K. Toide, M. Shinoda, M. Takase, K. Iwata, and H. Yoshida, Effects of a novel thyrotropin-releasing hormone analogue, JTP-2942, on extracellular acetylcholine and choline levels in the rat frontal cortex and hippocampus, Eur. J. Pharmacol. 233: 21 (1993).
A. Uemura, F. Yonemori, N. Furukawa, K. Toide, and K. Iwata, Effect of novel TRH analogue, JTP2942, on various amnesia models in rodents, Jpn. J. Pharmacol. 61 (Sup.): 187 (1993).
H. Yamada, S. Takeuchi, K. Toide, and K. Iwata, Effect and mechanism of action of a novel TRH analogue, JTP-2942, on Morris water maze spatial cognitive impairment in aged rats, Jpn. J. Pharmacol. 61 (Sup.): 92 (1993).
L.T. Rutledge, and T.T. Kennedy, Brain-stem and cortical interactions in the interhemispheric delayed response, Exp. Neurol. 4: 470 (1961).
F. Bremer, Le corpus calloeux dans la dynamique cerebrale, Experientia 22: 201 (1966).
G.O. Ivy, and H.P. Killackey, The ontogeny of the distribution of callosal projection neurons in the rat parietal cortex, J. Comp. Neurol. 195: 367 (1981).
G. Paxion, and C. Watson, “The rat brain in stereotaxic coordinates”, Academic Press, New York.
M.E. Jarvik, and A. Kopp, An improved one-trial passive avoidance, learning situation, Psychol. Rep. 27: 221 (1967).
J. Seggie, and M. Berry, Ontogeny of interhemispheric evoked potentials in the rat: significance of myelination of the corpus callosum, Exp. Neurol. 35: 215 (1972).
D.A. Wilson, and R.J. Racine, The postnatal development of post-activation potentiation in the rat neocortex, Develop. Brain Res. 7: 271 (1983).
D.A. Wilson, A comparison of the postnatal development of post-activation potentiation in the neocortex and dentate gyros of the rat, Develop. Brain Res. 16: 61 (1984).
V.L. Bianki, and V.A. Shramm, New evidence on the callosal system, Int. J. Neurosci. 25: 175 (1985).
S.Okuyama, and H. Aihara, Action of nootropic drugs on transcallosal responses in rats, Neuropharmacology 27: 67 (1988).
S.Okuyama, and H. Aihara, Effect of minaprine on synaptic transmission in the neocortex of the rat in vivo, Neuropharmacology 27: 915 (1988).
P. Black, and R.E. Myers, Brainstem mediation of visual perception in a higher primate, Trans. Am. Neurol. Assoc. 93: 191 (1968).
T.H. Meikle, and J.A. Sechzer, Interocular transfer of brightness discrimination in split-brain cats, Science 132: 734 (1960).
C.B. Trevarthen, Double visual learning in split-brain monkeys, Science 136: 258 (1962).
T.J. Hoffman, C.L. Sheridan, and D.M. Levinson, Interocular transfer in albino rats as a function of forebrain plus midbrain commissurotomy, Physiol. Behay. 27: 279 (1981).
T.H. Meikle, Failure of interocular transfer of brightness discrimination, Nature 202: 1243 (1964).
R. Thompson, and I. Rich, Differential effects of posterior thalamic lesions on retention of various visual habits, J. Comp. Physiol. Psychol. 56: 60 (1963).
R. Thompson, and P.H. Spiliotis, Subcortical lesions and retention of a brightness discrimination in the rat; Appetitive vs. aversive motivation, Physiol. Psychol. 9: 63 (1981).
C.K. Peck, S.G. Crewther, and C.R. Hamilton, Partial interocular transfer of brightness and movement discrimination by split-brain, Brain Res. 163: 61 (1979).
C.R. Butler, A memory-record for visual discrimination habits produced in both cerebral hemispheres of monkey when only one hemisphere has received direct visual information, Brain Res. 10: 152 (1968).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Yonemori, F., Yamada, H., Uemura, A., Takeuchi, S., Toide, K., Iwata, K. (1995). Effect of JTP-2942, a Novel TRH Analogue, on Cognitive Function and Learning in Rodents. In: Hanin, I., Yoshida, M., Fisher, A. (eds) Alzheimer’s and Parkinson’s Diseases. Advances in Behavioral Biology, vol 44. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9145-7_55
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9145-7_55
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9147-1
Online ISBN: 978-1-4757-9145-7
eBook Packages: Springer Book Archive